Výsledky vyhledávání

Akademický článek

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.

Autor: Egan KP; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Awasthi S; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Tebaldi G; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Hook LM; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Naughton AM; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Fowler BT; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Beattie M; Acuitas Therapeutics Inc., Vancouver, BC V6T 1Z3, Canada., Alameh MG; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Weissman D; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Cohen GH; Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Friedman HM; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Publikováno v: Viruses [Viruses] 2023 Jun 30; Vol. 15 (7). Date of Electronic Publication: 2023 Jun 30.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs.

Autor: Awasthi S; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Onishi M; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka 561-0825, Japan., Lubinski JM; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Fowler BT; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Naughton AM; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Hook LM; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Egan KP; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Hagiwara M; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka 561-0825, Japan., Shirai S; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka 561-0825, Japan., Sakai A; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka 561-0825, Japan., Nakagawa T; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka 561-0825, Japan., Goto K; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka 561-0825, Japan., Yoshida O; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka 561-0825, Japan., Stephens AJ; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Choi G; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Cohen GH; Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA., Katayama K; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka 561-0825, Japan., Friedman HM; Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA.

Publikováno v: Viruses [Viruses] 2023 May 10; Vol. 15 (5). Date of Electronic Publication: 2023 May 10.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

HepCare Ireland-a service innovation project.

Autor: Connolly SP; Mater Misericordiae University Hospital, Dublin 7, Ireland. sconnolly91@gmail.com.; University College Dublin, Dublin, Ireland. sconnolly91@gmail.com., Avramovic G; University College Dublin, Dublin, Ireland., Cullen W; University College Dublin, Dublin, Ireland., McHugh T; Mater Misericordiae University Hospital, Dublin 7, Ireland., O'Connor E; University College Dublin, Dublin, Ireland., Mc Combe G; University College Dublin, Dublin, Ireland., Crowley D; University College Dublin, Dublin, Ireland.; Irish Prison Service, Longford, Ireland., Naughton AM; Health Service Executive, Dublin, Ireland., Horan A; Health Service Executive, Dublin, Ireland., Lambert JS; Mater Misericordiae University Hospital, Dublin 7, Ireland.; University College Dublin, Dublin, Ireland.

Publikováno v: Irish journal of medical science [Ir J Med Sci] 2021 May; Vol. 190 (2), pp. 587-595. Date of Electronic Publication: 2020 Aug 06.

Zobrazit plný text záznamu

Akademický článek

HepCare Europe-A service innovation project. HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA.

Autor: Avramovic G; Mater Misericordiae University Hospital, Ireland; University College Dublin, Ireland., Oprea C; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Romania., Surey J; University College London, UK., Story A; University College London Hospital, UK., Macías J; Hospital Universitario de Valme, Spain., Cullen W; University College Dublin, Ireland., Iglesias M; Hospital Universitario de Valme, Spain., Mc Hugh T; Mater Misericordiae University Hospital, Ireland., Crowley D; Health Service Executive, Ireland., Naughton AM; Health Service Executive, Ireland., Horan A; Health Service Executive, Ireland., Ianache I; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Romania., Lazar S; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Romania., Popa I; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Romania., Menezes D; University College London, UK., Lambert JS; Mater Misericordiae University Hospital, Ireland; University College Dublin, Ireland. Electronic address: jlambert@mater.ie.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Feb; Vol. 91, pp. 246-251. Date of Electronic Publication: 2019 Nov 27.

Zobrazit plný text záznamu

Akademický článek

HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study.

Autor: Barror S; Mater Misericordiae University Hospital, Dublin, Ireland., Avramovic G; Mater Misericordiae University Hospital, Dublin, Ireland.; University College Dublin, Dublin, Ireland., Oprea C; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania., Surey J; University College London, London, UK., Story A; University College London Hospital, London, UK., Macías J; Hospital Universitario de Valme, Seville, Spain., Cullen W; Mater Misericordiae University Hospital, Dublin, Ireland., Crowley D; HSE, Cork, Ireland.; Irish Prison Service, Dublin, Ireland., Horan A; HSE, Cork, Ireland., Naughton AM; HSE, Cork, Ireland., Iglesias M; Hospital Universitario de Valme, Seville, Spain., Ianache I; University College London Hospital, London, UK., Lazar S; University College London Hospital, London, UK., Popa I; University College London Hospital, London, UK., McHugh T; Mater Misericordiae University Hospital, Dublin, Ireland., Menezes D; University College London, London, UK., Tinago W; University College Dublin, Dublin, Ireland., Lambert JS; Mater Misericordiae University Hospital, Dublin, Ireland.; University College Dublin, Dublin, Ireland.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Nov 01; Vol. 74 (Suppl 5), pp. v39-v46.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání